Cell Signaling Technology Logo
1% for the planet logo
Trial Size Available Flag
Recombinant Flag
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

UbcH5C (D60E2) Rabbit mAb #4330

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R Mk
    SENSITIVITY Endogenous
    MW (kDa) 14
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:100

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    UbcH5C (D60E2) Rabbit mAb detects endogenous levels of total UbcH5C protein.

    Species Reactivity:

    Human, Mouse, Rat, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp135 of human UbcH5C protein.

    Background

    Protein ubiquitination requires the concerted action of the E1, E2 and E3 ubiquitin-conjugating enzymes. Ubiquitin is first activated through an ATP-dependent formation of a thiol ester with an E1 enzyme. The activated ubiquitin is then transferred to a thiol-group of an E2 ubiquitin-conjugation enzyme. The final step is the transfer of ubiquitin from E2 to an ε-amino group of a lysine residue on the target protein, a transfer mediated by ubiquitin-conjugating enzyme E3 (1). UbcH5C is a universally expressed E2 ubiquitin conjugating enzyme and member of the UbcH5 family that also includes UbcH5A and UbcH5B (2). Evidence suggests that UbcH5C plays an important role in regulating a number of signaling pathways by catalyzing the ubiquitination of key target proteins, including p53, PCNA, the IκB kinase protein NEMO, and the apoptosis inhibitor BRUCE (3-6). Gene expression profiles revealed increased expression of UbcH5C in meibomian cell carcinoma and oncocytic thyroid adenomas (7,8), while an RNAi screen reveals diffrential Ubc5HC in acute promyelocytic cells (9). These results suggest a potential role of UbcH5C in cell cycle control and tumorigenesis.

    Alternate Names

    E217KB 3; E2conjugating; UBE2D3; Ubiquitin carrier protein D3; Ubiquitin-protein ligase D3

    For Research Use Only. Not for Use in Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.